Please assess the completion status of the following clinical trial:

Trial Title: Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Children ages 2 years to 7 years who present as patients to the Pediatric Emergency Department at Banner University Medical Center Tucson Campus~* Body weight of 20kg or less (actual, estimated, or measured)~* NPO for four hours or more~* Undergoing various procedures, which are deemed by the treating provider to require procedural sedation for the completion of the procedure.~Exclusion Criteria:~* Discretion of parents~* Discretion of provider~* Body weight greater than 20kg (actual, estimated, or measured)~* Starting Aldrete score \<9/10~* Known or suspected psychosis~* Known or suspected central nervous system mass, abnormalities, hydrocephalus, or other condition that would suggest elevated pre-anesthetic cerebrospinal fluid pressure~* Significant elevation in blood pressure~* Known hypersensitivity to ketamine~* Non-English or Spanish speaking

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 7 Years
- Healthy Volunteers: f

Study Arms:
- Intranasal ketamine arm (Type: EXPERIMENTAL): 10mg/kg intranasal ketamine administered one time

Based on this trial design, predict the completion outcome and termination type (if applicable).